Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
Frontiers in Pharmacology · 24.01.2024 · 15
DOI: 10.3389/fphar.2024.1350187 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.01.2024. Verfasst von Jianghu Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Affiliated Hospital of Guizhou Medical University, Guiyang, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteosarcoma (OS) is a malignant tumor originating from mesenchymal tissue. Pulmonary metastasis is usually present upon initial diagnosis, and metastasis is the primary factor affecting the poor prognosis of patients with OS. Current research shows that the ability to regulate the cellular microenvironment is essential for preventing the distant metastasis of OS, and anoxic microenvironments are important features of solid tumors. During hypoxia, hypoxia-inducible factor-1α (HIF-1α) expression levels and stability increase. Increased HIF-1α promotes tumor vascular remodeling, epithelial-mesenchymal transformation (EMT), and OS cells invasiveness; this leads to distant metastasis of OS cells. HIF-1α plays an essential role in the mechanisms of OS metastasis. In order to develop precise prognostic indicators and potential therapeutic targets for OS treatment, this review examines the molecular mechanisms of HIF-1α in the distant metastasis of OS cells; the signal transduction pathways mediated by HIF-1α are also discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
- Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu, China.
Zitieren
APA
Zhou, J., Lan, F., Liu, M., Wang, F., Ning, X., Yang, H., & Sun, H. (2024). Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1350187
Vancouver
Zhou J, Lan F, Liu M, Wang F, Ning X, Yang H, et al. Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1350187
BibTeX
@article{Zhou2024,
author = {Zhou, Jianghu and Lan, Fengjun and Liu, Miao and Wang, Fengyan and Ning, Xu and Yang, Hua and Sun, Hong},
title = {Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1350187}
}
EUVIMED